Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy
Links shared publicly online about this topic.
- 588total visits
Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy
View full resource at medicalnewstoday.com
Tags: Bone, Pharma, Children's Health
Most Recently Shared on January 11, 2011 at 4:05 pm By:
Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy http://mnt.to/3PR3
Also Shared By:
Enobia Announces Completion Of Enrollment In Third Phase II Hypophosphatasia Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy
medicalnewstoday.com — “Enobia Pharma Inc., announced that it has successfully completed enrollment in its Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in adolescents and adul” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2011 at 6:05 pm By:
MNT Bones/Orthopedic Health News
Enobia Announces Completion Of Enrollment In Third Phase II Hypophosphatasia Study Of ENB-0040, A Bone Targeted Enzyme... http://mnt.to/3RBV
Enobia completes patient enrollment in ENB-0040 Phase II study for HPP
news-medical.net — “Enobia Pharma Inc., today announced that it has successfully completed enrollment in its Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in adolescents and adults with hypophosphatasia, a serious, rare metabolic bone disorder.” View full resource at news-medical.net
Most Recently Shared on February 25, 2011 at 11:22 am By:
Genetics News: Enobia completes patient enrollment in ENB-0040 Phase II study for HPP: Enobia Pharma Inc., today... http://bit.ly/gqmKFN
Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy - Drugs.com MedNews
drugs.com — “Company Highlights Clinical Progress, Advances toward Commercial Preparedness at J.P. Morgan Healthcare Conference SAN FRANCISCO, Enobia Pharma Inc., today anno” View full resource at drugs.com
Most Recently Shared on January 11, 2011 at 7:13 pm By:
Drugs and Devices OW OW Health
Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Repl... http://bit.ly/ggrK1d #drug
Advertisement
MNT Bones/Orthopedic
@mnt_bones
Enobia Announces Completion Of Enrollment In Third Phase II Hypophosphatasia Study Of ENB-0040, A Bone Targeted Enzyme... http://mnt.to/3RBV
1 year ago...